Source 1review2024MED
Toolkit/ultrasound-responsive nanoparticles
ultrasound-responsive nanoparticles
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
We highlight the following technologies: ... ultrasound-responsive nanoparticles...
Usefulness & Problems
Why this is useful
Ultrasound-responsive nanoparticles are presented as therapeutic platforms for brain tumors that can be used for radiotherapy enhancement, gene delivery, immunotherapy, and sonodynamic therapy. The review frames them within ultrasound-guided precision delivery strategies.; brain tumor therapy; precision delivery under ultrasound visualization; gene delivery; immunotherapy; sonodynamic therapy; radiotherapy enhancement; Ultrasound-responsive nanoparticles are reviewed as an innovative technology relevant to Parkinson disease treatment.; ultrasound-coupled neuromodulatory or delivery strategies relevant to Parkinson disease
Source:
Ultrasound-responsive nanoparticles are presented as therapeutic platforms for brain tumors that can be used for radiotherapy enhancement, gene delivery, immunotherapy, and sonodynamic therapy. The review frames them within ultrasound-guided precision delivery strategies.
Source:
brain tumor therapy
Source:
precision delivery under ultrasound visualization
Source:
gene delivery
Source:
immunotherapy
Source:
sonodynamic therapy
Source:
radiotherapy enhancement
Source:
Ultrasound-responsive nanoparticles are reviewed as an innovative technology relevant to Parkinson disease treatment.
Source:
ultrasound-coupled neuromodulatory or delivery strategies relevant to Parkinson disease
Problem solved
They are discussed as a way to improve treatment of brain tumors where the blood-brain barrier limits therapeutic efficacy. The review emphasizes their role in personalized and precision treatment strategies.; supports therapeutic delivery strategies for brain tumors where BBB penetration is a critical barrier; They are included as part of promising neuromodulatory treatment strategies for PD motor symptoms.; adds a remotely responsive nanoparticle platform to the reviewed PD intervention space
Source:
They are discussed as a way to improve treatment of brain tumors where the blood-brain barrier limits therapeutic efficacy. The review emphasizes their role in personalized and precision treatment strategies.
Source:
supports therapeutic delivery strategies for brain tumors where BBB penetration is a critical barrier
Source:
They are included as part of promising neuromodulatory treatment strategies for PD motor symptoms.
Source:
adds a remotely responsive nanoparticle platform to the reviewed PD intervention space
Problem links
adds a remotely responsive nanoparticle platform to the reviewed PD intervention space
LiteratureThey are included as part of promising neuromodulatory treatment strategies for PD motor symptoms.
Source:
They are included as part of promising neuromodulatory treatment strategies for PD motor symptoms.
supports therapeutic delivery strategies for brain tumors where BBB penetration is a critical barrier
LiteratureThey are discussed as a way to improve treatment of brain tumors where the blood-brain barrier limits therapeutic efficacy. The review emphasizes their role in personalized and precision treatment strategies.
Source:
They are discussed as a way to improve treatment of brain tumors where the blood-brain barrier limits therapeutic efficacy. The review emphasizes their role in personalized and precision treatment strategies.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Mechanisms
cavitationenhanced vesicular transport in endothelial cellsmodulation of tight junction protein expressiontransient blood-brain barrier openingTranslation ControlTechniques
Computational DesignTarget processes
translationInput: Light
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: externally suppliedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: delivery
The abstract places these nanoparticles in workflows using ultrasound visualization and precise control of ultrasound parameters. BBB penetration is a central implementation consideration in the brain tumor setting.; requires ultrasound-responsive nanoparticle formulation; brain tumor use is discussed in the context of ultrasound visualization and parameter control; Their use implies both a nanoparticle system and an ultrasound actuation setup, though the abstract does not specify either in detail.; requires nanoparticle formulation and ultrasound actuation details not provided in the abstract
The abstract does not show that nanoparticles alone solve BBB penetration in all cases, and instead highlights BBB penetration as an ongoing critical challenge. It also does not provide specific performance data for any one nanoparticle system.; therapeutic efficacy in brain tumors is constrained by the blood-brain barrier; The abstract does not state what delivery, targeting, or safety issues remain unresolved.; the abstract does not specify composition, cargo, ultrasound parameters, or efficacy limits
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2primary paper2025MED
Ranked Claims
Ultrasound-responsive nanoparticles are applied in brain tumor therapy for enhanced radiotherapy, gene delivery, immunotherapy, and sonodynamic therapy.
Focused ultrasound combined with microbubbles can transiently open the blood-brain barrier.
Focused ultrasound combined with microbubbles opens the blood-brain barrier through cavitation, modulation of tight junction protein expression, and enhanced vesicular transport in endothelial cells.
Ultrasound-responsive nanoparticles have clinical translation potential for personalized and precision treatment of brain tumors.
The reviewed studies establish the basis for novel and promising neuromodulatory treatments for Parkinson disease motor symptoms.
These studies establish the basis for novel and promising neuromodulatory treatments for PD motor symptoms.
The review summarizes preclinical and clinical trials investigating innovative neuromodulatory approaches for Parkinson disease motor symptom management.
In this review, we summarize preclinical and clinical trials investigating innovative neuromodulatory approaches for Parkinson disease (PD) motor symptom management.
The review highlights temporal interference, nanoparticles for drug delivery, blood-brain barrier opening, gene therapy, optogenetics, upconversion nanoparticles, magnetothermal nanoparticles, magnetoelectric nanoparticles, ultrasound-responsive nanoparticles, and DREADDs as relevant technologies for Parkinson disease.
We highlight the following technologies: temporal interference, nanoparticles for drug delivery, blood-brain barrier opening, gene therapy, optogenetics, upconversion nanoparticles, magnetothermal nanoparticles, magnetoelectric nanoparticles, ultrasound-responsive nanoparticles, and designer receptors exclusively activated by designer drugs.
Approval Evidence
2 sources5 linked approval claimsfirst-pass slug ultrasound-responsive-nanoparticles
We discuss the applications of ultrasound-responsive nanoparticles in brain tumor therapy, including enhanced radiotherapy, gene delivery, immunotherapy, and sonodynamic therapy (SDT).
Source:
We highlight the following technologies: ... ultrasound-responsive nanoparticles...
Source:
application scopesupports
Ultrasound-responsive nanoparticles are applied in brain tumor therapy for enhanced radiotherapy, gene delivery, immunotherapy, and sonodynamic therapy.
Source:
translation potentialsupports
Ultrasound-responsive nanoparticles have clinical translation potential for personalized and precision treatment of brain tumors.
Source:
promise assessmentsupports
The reviewed studies establish the basis for novel and promising neuromodulatory treatments for Parkinson disease motor symptoms.
These studies establish the basis for novel and promising neuromodulatory treatments for PD motor symptoms.
Source:
review scope summarysupports
The review summarizes preclinical and clinical trials investigating innovative neuromodulatory approaches for Parkinson disease motor symptom management.
In this review, we summarize preclinical and clinical trials investigating innovative neuromodulatory approaches for Parkinson disease (PD) motor symptom management.
Source:
technology scopesupports
The review highlights temporal interference, nanoparticles for drug delivery, blood-brain barrier opening, gene therapy, optogenetics, upconversion nanoparticles, magnetothermal nanoparticles, magnetoelectric nanoparticles, ultrasound-responsive nanoparticles, and DREADDs as relevant technologies for Parkinson disease.
We highlight the following technologies: temporal interference, nanoparticles for drug delivery, blood-brain barrier opening, gene therapy, optogenetics, upconversion nanoparticles, magnetothermal nanoparticles, magnetoelectric nanoparticles, ultrasound-responsive nanoparticles, and designer receptors exclusively activated by designer drugs.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts these approaches with conventional surgery, radiotherapy, and chemotherapy, which still leave poor survival. It also specifically discusses focused ultrasound plus microbubbles as a BBB-opening enabling strategy.; The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Source:
The abstract contrasts these approaches with conventional surgery, radiotherapy, and chemotherapy, which still leave poor survival. It also specifically discusses focused ultrasound plus microbubbles as a BBB-opening enabling strategy.
Source:
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Source-backed strengths
positioned for multiple therapeutic application modes in brain tumors; framed for personalized and precision treatment; explicitly highlighted as a technology in the review
Source:
positioned for multiple therapeutic application modes in brain tumors
Source:
framed for personalized and precision treatment
Source:
explicitly highlighted as a technology in the review
Compared with chemogenetics
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Shared frame: source-stated alternative in extracted literature
Strengths here: positioned for multiple therapeutic application modes in brain tumors; framed for personalized and precision treatment; explicitly highlighted as a technology in the review.
Relative tradeoffs: therapeutic efficacy in brain tumors is constrained by the blood-brain barrier; the abstract does not specify composition, cargo, ultrasound parameters, or efficacy limits.
Source:
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Compared with designer GPCRs
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Shared frame: source-stated alternative in extracted literature
Strengths here: positioned for multiple therapeutic application modes in brain tumors; framed for personalized and precision treatment; explicitly highlighted as a technology in the review.
Relative tradeoffs: therapeutic efficacy in brain tumors is constrained by the blood-brain barrier; the abstract does not specify composition, cargo, ultrasound parameters, or efficacy limits.
Source:
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Compared with focused ultrasound
The abstract contrasts these approaches with conventional surgery, radiotherapy, and chemotherapy, which still leave poor survival. It also specifically discusses focused ultrasound plus microbubbles as a BBB-opening enabling strategy.
Shared frame: source-stated alternative in extracted literature
Strengths here: positioned for multiple therapeutic application modes in brain tumors; framed for personalized and precision treatment; explicitly highlighted as a technology in the review.
Relative tradeoffs: therapeutic efficacy in brain tumors is constrained by the blood-brain barrier; the abstract does not specify composition, cargo, ultrasound parameters, or efficacy limits.
Source:
The abstract contrasts these approaches with conventional surgery, radiotherapy, and chemotherapy, which still leave poor survival. It also specifically discusses focused ultrasound plus microbubbles as a BBB-opening enabling strategy.
Compared with optogenetic functional interrogation
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Shared frame: source-stated alternative in extracted literature
Strengths here: positioned for multiple therapeutic application modes in brain tumors; framed for personalized and precision treatment; explicitly highlighted as a technology in the review.
Relative tradeoffs: therapeutic efficacy in brain tumors is constrained by the blood-brain barrier; the abstract does not specify composition, cargo, ultrasound parameters, or efficacy limits.
Source:
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Compared with optogenetic membrane potential perturbation
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Shared frame: source-stated alternative in extracted literature
Strengths here: positioned for multiple therapeutic application modes in brain tumors; framed for personalized and precision treatment; explicitly highlighted as a technology in the review.
Relative tradeoffs: therapeutic efficacy in brain tumors is constrained by the blood-brain barrier; the abstract does not specify composition, cargo, ultrasound parameters, or efficacy limits.
Source:
The review also covers blood-brain barrier opening, other nanoparticle classes, optogenetics, and DREADDs.
Compared with ultrasonography
The abstract contrasts these approaches with conventional surgery, radiotherapy, and chemotherapy, which still leave poor survival. It also specifically discusses focused ultrasound plus microbubbles as a BBB-opening enabling strategy.
Shared frame: source-stated alternative in extracted literature
Strengths here: positioned for multiple therapeutic application modes in brain tumors; framed for personalized and precision treatment; explicitly highlighted as a technology in the review.
Relative tradeoffs: therapeutic efficacy in brain tumors is constrained by the blood-brain barrier; the abstract does not specify composition, cargo, ultrasound parameters, or efficacy limits.
Source:
The abstract contrasts these approaches with conventional surgery, radiotherapy, and chemotherapy, which still leave poor survival. It also specifically discusses focused ultrasound plus microbubbles as a BBB-opening enabling strategy.
Ranked Citations
- 1.
- 2.